|
|
|
|
|
|
|
Mon T W Th F |
|
27 July, 2026 |
|
|
sponsored by
|
|
|
|
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
|
| Snapdragon Chemistry, together with NewAmsterdam Pharma, has received the American Chemical Society’s 2026 Green Chemistry Challenge Award for the Greener Synthetic Pathway in the Synthesis of Pharmaceuticals. Additionally, Cambrex continues to further its sustainability leadership, with its Milan facility receiving the EcoVadis Gold rating, placing it among the top 5% of organizations evaluated for environmental, social and ethical performance. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trying to right itself after a rough year, Sarepta has named Michael Severino to replace longtime head Doug Ingram. Lei Lei Wu has an exclusive first interview with the new CEO. |
|
|
|
Karen Weintraub |
Deputy Editor, Endpoints News
|
|
|
|
 |
|
Michael Severino, new Sarepta CEO |
|
|
|
by Lei Lei Wu
|
Sarepta Therapeutics has found its new CEO as it seeks to recover from a calamitous past year. Michael Severino will replace the company’s longtime leader... | |
|
|
|
|
|
|
by Ayisha Sharma
|
MapLight Therapeutics’ stock MPLT plummeted more than 60% on Monday after a once-daily regimen of its schizophrenia drug missed the primary endpoint in a mid-stage... | |
|
|
|
|
|
 |
|
Ying Huang at the Financial Times' Global Pharma and Biotech Summit in 2025 (courtesy Financial Times) |
|
|
|
by Max Gelman
|
Legend Biotech, the developer of the blockbuster cancer therapy Carvykti, is in the market for a new CEO. Ying Huang stepped down Friday after serving... | |
|
|
|
